Entity
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
type I IFN
--
e11
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m11
0
infinite
0
--
type I IFN:IFNAR1:JAK1:IFNAR2:TYK2
--
e12
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m12
0
infinite
0
--
type I IFN:IFNAR1:JAK1{active}:IFNAR2:TYK2{active}
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m13
0
infinite
0
--
stat1{p}:stat2
--
e14
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m14
0
infinite
0
--
stat1{p}
--
e15
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
stat1
--
e16
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m16
0
infinite
0
--
Stat2
--
e17
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m17
0
infinite
0
--
stat1{p}:stat2
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
ISRE elements
--
e19
cso30:c:Dna
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
csml-variable:Double
m20
0
infinite
0
--
IRF9
--
e21
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m21
0
infinite
0
--
ISGF3 complex
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m22
0
infinite
0
--
IFN-gamma
--
e23
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
IFNGR1:JAK1
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m24
0
infinite
0
--
IFNGR2:JAK2
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m25
0
infinite
0
--
IFNGR1:JAK1:IFNGR2:JAK2:IFN-gamma
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
IFNGR1:JAK1{active}:IFNGR2:JAK2{active}:IFN-gamma
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
IFNGR1{p}:JAK1{active}:IFNGR2{p}:JAK2{active}:IFN-gamma
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
IFNGR1{p}:JAK1{active}:IFNGR2{p}:JAK2{active}:IFN-gamma:stat1
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
IFNGR1{p}:JAK1{active}:IFNGR2{p}:JAK2{active}:IFN-gamma:stat1{p}
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
(stat1{p})2
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m31
0
infinite
0
--
(stat1{p})2
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
csml-variable:Double
m33
0
infinite
0
--
csml-variable:Double
m34
0
infinite
0
--
IL-1R
--
e35
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m35
0
infinite
0
--
Twist
--
e36
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m36
0
infinite
0
--
Twist:TNF-alpha
--
e37
cso30:c:Complex
cso30:i:CC_NuclearChromosome
--
--
csml-variable:Double
m37
0
infinite
0
--
csml-variable:Double
m38
0
infinite
0
--
IL-4R
--
e39
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
IFN-alpha
--
e40
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m40
0
infinite
0
--
Twist
--
e41
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m41
0
infinite
0
--
Twist
--
e42
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m42
0
infinite
0
--
Axl
--
e43
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m43
0
infinite
0
--
Axl
--
e44
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
LPS
--
e45
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m45
0
infinite
0
--
NF-kappaB
--
e46
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
NF-kappaB{active}
--
e47
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m47
0
infinite
0
--
Ig complex
--
e48
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m48
0
infinite
0
--
TNF-alpha
--
e49
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m49
0
infinite
0
--
IFNAR1:JAK1
--
e5
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
IFNAR2:TYK2
--
e6
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
csml-variable:Double
m63
0
infinite
0
--
csml-variable:Double
m64
0
infinite
0
--
PERK
--
e65
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m65
0
infinite
0
--
csml-variable:Double
m66
0
infinite
0
--
csml-variable:Double
m67
0
infinite
0
--
(stat1{p})2{active}
--
e68
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m68
0
infinite
0
--
p38MAPK
--
e69
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m69
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
TTP
--
e70
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m70
0
infinite
0
--
TTP
--
e71
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m71
0
infinite
0
--
TNF-alpha
--
e72
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m72
0
infinite
0
--
PERK{active}
--
e73
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m73
0
infinite
0
--
eIF2alpha{p}
--
e74
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m74
0
infinite
0
--
eIF2alpha
--
e75
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m75
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
stoichiometry:c4 : 1
m5*m6*m11*0.1
nodelay
--
0
PMID: 18086388, 15546383, 10526569 Binding of type I IFNs to their receptor (composed of the IFNAR1 and IFNAR2 subunits) activates the receptor-associated tyrosine kinases Jak1 and Tyk2 causing phosphorylation of the receptor and, subsequently, recruitment and phosphorylation of the Stat transcription factors
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m27*0.1
nodelay
--
0
PMID: 18086388 The receptor-associated Jak1 and Jak2 tyrosine kinases are activated and phosphorylate the receptor, thereby generating a docking site for the SH2 domain of Stat1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c30 : 1
stoichiometry:c31 : 1
m28*m16*0.1
nodelay
--
0
PMID: 18086388 The receptor-associated Jak1 and Jak2 tyrosine kinases are activated and phosphorylate the receptor, thereby generating a docking site for the SH2 domain of Stat1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m29*0.1
nodelay
--
0
PMID: 18086388 After phosphorylation by Jaks Stat1:Stat1 dimers translocate to the nucleus and activate transcription by binding to the GAS elements of IFN-¦Ã responsive genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m30*0.1
nodelay
--
0
PMID: 18086388 After phosphorylation by Jaks Stat1:Stat1 dimers translocate to the nucleus and activate transcription by binding to the GAS elements of IFN-¦Ã responsive genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c38 : 1
m15*0.1
nodelay
--
0
PMID: 18086388 After phosphorylation by Jaks Stat1:Stat1 dimers translocate to the nucleus and activate transcription by binding to the GAS elements of IFN-¦Ã responsive genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c40 : 1
m31*0.1
nodelay
--
0
PMID: 18086388 After phosphorylation by Jaks Stat1:Stat1 dimers translocate to the nucleus and activate transcription by binding to the GAS elements of IFN-¦Ã responsive genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c42 : 1
stoichiometry:c43 : 1
m32*m33*0.1
nodelay
--
0
PMID: 18086388 After phosphorylation by Jaks Stat1:Stat1 dimers translocate to the nucleus and activate transcription by binding to the GAS elements of IFN-¦Ã responsive genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c44 : 1
1.0*0.1
nodelay
--
0
PMID: 18086388, 15972639 The work by Hu and colleagues shows that IFN-¦Ã suppresses the expression of the IL-1 receptor in macrophages making the cells refractory to IL-1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c48 : 1
stoichiometry:c47 : 1
m38*m36*0.1
nodelay
--
0
PMID: 18086388, 12553906 Twist proteins are transcriptional repressors that bind to the E-boxes in gene promoters, such as the TNF-¦Á promoter, and inhibit transcription
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c51 : 1
stoichiometry:c49 : 1
1.0*0.1
nodelay
--
0
PMID: 18086388, 11067899 Both IFN-¦Á and IFN-¦Ã were found to decrease the IL-4 receptor gene expression
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m12*0.1
nodelay
--
0
PMID: 18086388, 15546383, 10526569 Binding of type I IFNs to their receptor (composed of the IFNAR1 and IFNAR2 subunits) activates the receptor-associated tyrosine kinases Jak1 and Tyk2 causing phosphorylation of the receptor and, subsequently, recruitment and phosphorylation of the Stat transcription factors
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c52 : 1
m44*0.1
nodelay
--
0
PMID: 18086388 type I IFNs increase the amount of Twist proteins in cells and, consequently, the pre-treatment of macrophages with type I IFNs reduces the capability of immunoglobulin complexes or LPS to stimulate the NF-¦ÊB-mediated expression of TNF-¦Á.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c59 : 1
stoichiometry:c54 : 1
m41*m44*0.1
nodelay
--
0
PMID: 18086388 type I IFNs increase the amount of Twist proteins in cells and, consequently, the pre-treatment of macrophages with type I IFNs reduces the capability of immunoglobulin complexes or LPS to stimulate the NF-¦ÊB-mediated expression of TNF-¦Á.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c55 : 1
m13*0.1
nodelay
--
0
PMID: 18086388 The up-regulation of Twist by IFNs was indirect and required the IFN-induced expression of the receptor tyrosine kinase Axl.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
stoichiometry:c62 : 1
m45*m46*0.1
nodelay
--
0
PMID: 18086388 type I IFNs increase the amount of Twist proteins in cells and, consequently, the pre-treatment of macrophages with type I IFNs reduces the capability of immunoglobulin complexes or LPS to stimulate the NF-¦ÊB-mediated expression of TNF-¦Á.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c65 : 1
stoichiometry:c64 : 1
m46*m48*0.1
nodelay
--
0
PMID: 18086388 type I IFNs increase the amount of Twist proteins in cells and, consequently, the pre-treatment of macrophages with type I IFNs reduces the capability of immunoglobulin complexes or LPS to stimulate the NF-¦ÊB-mediated expression of TNF-¦Á.
p25
p25
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c68 : 1
stoichiometry:c86 : 1
stoichiometry:c69 : 1
m47*0.1
nodelay
--
0
PMID: 18086388 type I IFNs increase the amount of Twist proteins in cells and, consequently, the pre-treatment of macrophages with type I IFNs reduces the capability of immunoglobulin complexes or LPS to stimulate the NF-¦ÊB-mediated expression of TNF-¦Á. PMID: 18086388 TTP limits the production of TNF-¦Á under these conditions
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c73 : 1
stoichiometry:c72 : 1
m64*m40*0.1
nodelay
--
0
PMID: 18086388, 16571725 In their paper, Ho and Ivashkiv show that IFN-¦Á-activated Stat3 inhibited, in a dose-dependent manner, the transcription of genes that are regulated by Stat1:Stat1 homodimers while the transcription of the ISGF3 (Stat1:Stat2:IRF9) target genes remained unaffected.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c67 : 1
stoichiometry:c66 : 1
m43*m13*0.1
nodelay
--
0
PMID: 18086388 The up-regulation of Twist by IFNs was indirect and required the IFN-induced expression of the receptor tyrosine kinase Axl.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c75 : 1
m34*0.1
nodelay
--
0
PMID: 18086388, 16571725 In their paper, Ho and Ivashkiv show that IFN-¦Á-activated Stat3 inhibited, in a dose-dependent manner, the transcription of genes that are regulated by Stat1:Stat1 homodimers while the transcription of the ISGF3 (Stat1:Stat2:IRF9) target genes remained unaffected.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c81 : 1
stoichiometry:c77 : 1
m32*m69*0.1
nodelay
--
0
PMID: 18086388 Stat1 is recruited to the TTP promoter regardless of p38 MAPK activation, but it requires p38 MAPK to become transcriptionally active.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c9 : 1
stoichiometry:c8 : 1
m16*m13*0.1
nodelay
--
0
PMID: 18086388, 11226159, 12671680, 14670297, 7543024 For full responses to both type I and type II IFNs the transactivation domain of Stat1 needs to be phosphorylated on serine 727
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c80 : 1
stoichiometry:c79 : 1
m66*m68*0.1
nodelay
--
0
PMID: 18086388 Stat1 is recruited to the TTP promoter regardless of p38 MAPK activation, but it requires p38 MAPK to become transcriptionally active.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c84 : 1
m70*0.1
nodelay
--
0
PMID: 18086388 We have demonstrated that both types of IFNs can, in a Stat1-dependent way, induce TTP provided the stress-regulated p38 MAPK is activated simultaneously.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c83 : 1
m67*0.1
nodelay
--
0
PMID: 18086388 We have demonstrated that both types of IFNs can, in a Stat1-dependent way, induce TTP provided the stress-regulated p38 MAPK is activated simultaneously.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c88 : 1
stoichiometry:c89 : 1
stoichiometry:c87 : 1
m49*0.1
nodelay
--
0
PMID: 18086388 TTP limits the production of TNF-¦Á under these conditions
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c95 : 1
stoichiometry:c94 : 1
m65*m23*0.1
nodelay
--
0
PMID: 18086388 The cytoprotection was caused by the IFN-¦Ã-mediated induction of ER stress via activation of the pancreatic ER kinase (PERK).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c92 : 1
stoichiometry:c90 : 1
m66*m40*0.1
nodelay
--
0
PMID: 18086388 in human endothelial cells IFN-¦Á can stimulate TTP transcription even without simultaneous p38 MAPK activation, suggesting that in these cells type I IFNs may directly elicit the TTP-dependent anti-inflammatory responses
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c98 : 1
stoichiometry:c97 : 1
m75*m73*0.1
nodelay
--
0
PMID: 18086388 ER stress and PERK activation result in phosphorylation of the ¦Á subunit of the eukaryotic translation initiation factor 2 (eIF2¦Á).
PMID: 18086388 eIF2a phosphorylation imposes a strong reduction in translation that was previously associated with increased resistance to stress
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m15*m17*0.1
nodelay
--
0
PMID: 18086388, 8608598, 16571725, 8608597 Stat1 and Stat2 are essential for type I IFN responses whereas the still largely elusive role of Stat3 phosphorylation has only recently begun to emerge
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
m14*0.1
nodelay
--
0
PMID: 18086388 After translocation to the nucleus Stat complexes bind to distinct enhancer elements and activate transcription of the type I IFN-responsive genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c16 : 1
stoichiometry:c17 : 1
m21*m18*0.1
nodelay
--
0
PMID: 18086388 Herein, the ISGF3 complex consisting of a Stat1:Stat2 heterodimer and the DNA-binding subunit IRF9, which binds to ISRE elements, plays a more important role than the Stat1:Stat1 homodimer that binds to GAS elements.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c19 : 1
stoichiometry:c20 : 1
m19*m22*0.1
nodelay
--
0
PMID: 18086388 Herein, the ISGF3 complex consisting of a Stat1:Stat2 heterodimer and the DNA-binding subunit IRF9, which binds to ISRE elements, plays a more important role than the Stat1:Stat1 homodimer that binds to GAS elements.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m24*m23*m25*0.1
nodelay
--
0
PMID: 18086388 Type II IFN signalling is initiated by binding of IFN-¦Ã to its receptor consisting of the IFNGR1 and IFNGR2 subunits.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
m26*0.1
nodelay
--
0
PMID: 18086388 The receptor-associated Jak1 and Jak2 tyrosine kinases are activated and phosphorylate the receptor, thereby generating a docking site for the SH2 domain of Stat1.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--